Federico Vozella

411 total citations
31 papers, 241 citations indexed

About

Federico Vozella is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Federico Vozella has authored 31 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 20 papers in Genetics and 6 papers in Rheumatology. Recurrent topics in Federico Vozella's work include Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Acute Myeloid Leukemia Research (7 papers). Federico Vozella is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Acute Myeloid Leukemia Research (7 papers). Federico Vozella collaborates with scholars based in Italy and United States. Federico Vozella's co-authors include Maria Teresa Petrucci, Roberto Latagliata, Emilia Scalzulli, Sara Grammatico, Maria Teresa Petrucci, Ida Carmosino, Massimo Breccia, Giuliana Alimena, Marco Mancini and Michelina Santopietro and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cells.

In The Last Decade

Federico Vozella

28 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Federico Vozella Italy	10	162	82	81	78	46	31	241
Vittorio Del Fabro Italy	9	134 0.8×	100 1.2×	74 0.9×	93 1.2×	37 0.8×	32	263
Özgür Mehtap Türkiye	11	73 0.5×	68 0.8×	51 0.6×	58 0.7×	41 0.9×	34	257
Gergely Varga Hungary	10	154 1.0×	121 1.5×	51 0.6×	79 1.0×	10 0.2×	40	239
Ghaith Abu‐Zeinah United States	7	98 0.6×	96 1.2×	145 1.8×	31 0.4×	118 2.6×	44	254
Christos Poziopoulos Greece	10	186 1.1×	118 1.4×	81 1.0×	95 1.2×	22 0.5×	19	259
Alessandra Cupri Italy	11	214 1.3×	67 0.8×	88 1.1×	76 1.0×	33 0.7×	27	313
Manuela Rizzo Italy	7	186 1.1×	133 1.6×	68 0.8×	110 1.4×	6 0.1×	28	378
Liliya Sivcheva Poland	3	198 1.2×	30 0.4×	96 1.2×	11 0.1×	27 0.6×	3	262
Dina Sameh Soliman Qatar	8	87 0.5×	42 0.5×	83 1.0×	42 0.5×	13 0.3×	65	208
Gioia Colafigli Italy	11	270 1.7×	99 1.2×	178 2.2×	54 0.7×	61 1.3×	41	333

Countries citing papers authored by Federico Vozella

Since Specialization

Citations

This map shows the geographic impact of Federico Vozella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Vozella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Vozella more than expected).

Fields of papers citing papers by Federico Vozella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Vozella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Vozella. The network helps show where Federico Vozella may publish in the future.

Co-authorship network of co-authors of Federico Vozella

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Vozella. A scholar is included among the top collaborators of Federico Vozella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Vozella. Federico Vozella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carotti, Simone, Federico Vozella, Chiara Taffon, et al.. (2025). Autoimmune hepatitis with syncytial giant cells in chronic lymphocytic leukemia: A case report and literature review. World Journal of Hepatology. 17(7). 106253–106253.

Vozella, Federico, Maria Teresa Rizzo, Tommaso Zà, et al.. (2021). Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group. Annals of Hematology. 100(4). 1059–1063. 7 indexed citations

Vozella, Federico, et al.. (2021). Monoclonal antibodies in multiple myeloma. Panminerva Medica. 63(1). 21–27. 12 indexed citations

Serrao, Alessandra, Antonella Bruzzese, Cristina Santoro, et al.. (2020). PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count. Journal of Thrombosis and Thrombolysis. 49(3). 426–430. 11 indexed citations

Carmosino, Ida, Massimo Breccia, Sara Mohamed, et al.. (2019). Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib. Oncology Research and Treatment. 42(12). 660–664. 3 indexed citations

Latagliata, Roberto, Massimo Breccia, Ida Carmosino, et al.. (2018). Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?. European Journal Of Haematology. 101(5). 578–584. 1 indexed citations

Vitarelli, Antonio, Maria Teresa Petrucci, Silvia Lai, et al.. (2018). Dataset on the use of 3D speckle tracking echocardiography in light-chain amyloidosis. Data in Brief. 18. 1239–1246. 1 indexed citations

Vitarelli, Antonio, Silvia Lai, Maria Teresa Petrucci, et al.. (2018). Biventricular assessment of light-chain amyloidosis using 3D speckle tracking echocardiography: Differentiation from other forms of myocardial hypertrophy. International Journal of Cardiology. 271. 371–377. 19 indexed citations

Scalzulli, Emilia, Sara Grammatico, Federico Vozella, & Maria Teresa Petrucci. (2018). Proteasome inhibitors for the treatment of multiple myeloma. Expert Opinion on Pharmacotherapy. 19(4). 375–386. 33 indexed citations

10.

Latagliata, Roberto, Angela Romano, Marco Mancini, et al.. (2015). Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response. Leukemia & lymphoma. 57(1). 99–102. 9 indexed citations

11.

Latagliata, Roberto, Massimo Breccia, Ida Carmosino, et al.. (2015). Event-Free Survival According to Age in Patients with Chronic Myeloid Leukemia Receiving Imatinib Frontline: The Younger, the Later, the Worse?. Blood. 126(23). 4038–4038. 1 indexed citations

12.

Breccia, Massimo, Clara Minotti, Ida Carmosino, et al.. (2014). Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age. Annals of Hematology. 94(2). 195–200. 10 indexed citations

13.

Latagliata, Roberto, Massimo Breccia, Federico Vozella, et al.. (2014). Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib. American Journal of Hematology. 90(2). 105–108. 8 indexed citations

14.

Latagliata, Roberto, Ida Carmosino, Federico Vozella, et al.. (2013). Exclusion Criteria In The Dasision and Enestnd Trials: Which Could Their Impact Be On The Front-Line Treatment Of a “Real-life” Patient Population With Chronic Myelogenous Leukemia?. Blood. 122(21). 4002–4002.

15.

Latagliata, Roberto, Alessandro Isidori, Massimo Breccia, et al.. (2012). Complete Clearance of Ph+ Metaphases after 3 Months Is a Very Early Indicator of Good Response to Imatinib as Front-Line Treatment in Chronic Myelogenous Leukemia. Acta Haematologica. 129(2). 126–134. 4 indexed citations

16.

Latagliata, Roberto, Massimo Breccia, Ida Carmosino, et al.. (2010). “Real-life” results of front-line treatment with Imatinib in older patients (≥65 years) with newly diagnosed chronic myelogenous leukemia. Leukemia Research. 34(11). 1472–1475. 35 indexed citations

17.

Latagliata, Roberto, Angela Rago, Antonio Spadea, et al.. (2009). Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results. International Journal of Hematology. 90(4). 486–491. 1 indexed citations

18.

Latagliata, Roberto, Massimo Breccia, Ida Carmosino, et al.. (2008). Pregnancy in patients with myelodysplastic syndromes (MDS). Leukemia Research. 32(10). 1605–1607. 2 indexed citations

19.

Latagliata, Roberto, Esther N. Oliva, Ida Carmosino, et al.. (2008). Twice-Weekly High-Dose rHuEpo for the Treatment of Anemia in Patients with Low-Risk Myelodysplastic Syndromes. Acta Haematologica. 120(2). 104–107. 17 indexed citations

20.

Breccia, Massimo, Simona Sica, Antonio Spadea, et al.. (2008). Treatment with Imatinib in Very Elderly (> 75 Years) CML Patients.. Blood. 112(11). 1096–1096. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact